QEA

Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid

Product code
QEA
Device name
Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid
Device class
Class 2
21 CFR
21 CFR 882.1455
Medical specialty
Neurology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
2
Summaries archived here
2 (direct download)
510(k) clearances (all years, FDA)
7 (all years; only the last 3 years are listed here)

FDA classification definition

A traumatic brain injury eye movement assessment aid is a prescription device that uses a patient’s tracked eye movements to provide an interpretation of the functional condition of the patient’s brain. This device is an assessment aid that is not intended for standalone detection or diagnostic purposes.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (2)

Last three years. Most recent: 2026-06-05.

NumberDecision dateApplicantDevice nameSummary
K2540862026-06-05Oculogica, Inc.EyeBOX SNAPPDF
K2421162025-04-04Oculogica, Inc.EyeBOX EBX-4.1PDF

2 summaries are archived here for direct download.

Official FDA classification page: QEA
Classification and pathway per current FDA publications. Data from openFDA (CC0).